Soluble receptor for advanced glycation end products (sRAGE) attenuates haemodynamic changes to chronic hypoxia in the mouse

Pulmonary Pharmacology and Therapeutics

Volumn 29, Issue 1, 2014, Pages 7-14

  Farmer, David G S ^a   Ewart, Marie Ann ^a   Mair, Kirsty M ^a   Kennedy, Simon ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Fibroblasts; Hypoxia; MTS1 S100A4; Pulmonary hypertension; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALVASCULIN; POTASSIUM CHLORIDE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL REACTIVITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART RIGHT VENTRICLE PRESSURE; HYPOBARISM; HYPOXIA; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG FIBROBLAST; LUNG HEMODYNAMICS; MALE; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; VASODILATATION; ANIMAL; ANOXIA; C57BL MOUSE; CELL LINE; COMPLICATION; CRICETULUS; DISEASE MODEL; FIBROBLAST; HAMSTER; HEMODYNAMICS; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR REMODELING;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANOXIA; CELL LINE; CELL PROLIFERATION; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; FIBROBLASTS; HEMODYNAMICS; HYPERTENSION, PULMONARY; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; PULMONARY ARTERY; SEROTONIN; VASCULAR REMODELING;

EID: 84906938916     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2014.01.002     Document Type: Article

References (36)

1. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008, 196:9-21.
2. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Pinsky D., et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993, 143:1699-1712.
3. Brown R.D., Ambler S.K., Li M., Sullivan T.M., Henry L.N., Crossno J.T., et al. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2013, 304:H269-H281.
4. Dempsie Y., MacLean M.R. Pulmonary hypertension: therapeutic targets within the serotonin system. Br J Pharmacol 2008, 155:455-462.
5. Greenway S., van Suylen R.J., Du Marchie Sarvaas G., Kwan E., Ambartsumian N., Lukanidin E., et al. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 2004, 164:253-262.
6. Harja E., Bu D.-X., Hudson B.I., Jong S.C., Shen X., Hallam K., et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. JClin Invest 2008, 118:183-194.
7. Hopkins N., McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?. JAnat 2002, 201:335-348.
8. Humbert M., Morrell N.W., Archer S.L., Stenmark K.R., MacLean M.R., Lang I.M., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. JAm Coll Cardiol 2004, 43:13S-24S.
9. Jeffery T.K., Morrell N.W. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 2002, 45:173-202.
10. Keegan A., Morecroft I., Smillie D., Hicks M.N., MacLean M.R. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935. Circ Res 2001, 89:1231-1239.
11. Lawrie A., Spiekerkoetter E., Martinez E.C., Ambartsumian N., Sheward W.J., MacLean M.R., et al. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 2005, 97:227-235.
12. Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. JBiol Chem 2007, 282:31317-31331.
13. Maclean M.R., Dempsie Y. The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol 2010, 661:309-322.
14. MacLean M.R., Deuchar G.A., Hicks M.N., Morecroft I., Shen S., Sheward J., et al. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 2004, 109:2150-2155.
15. Mair K.M., MacLean M.R., Morecroft I., Dempsie Y., Palmer T.M. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase invivo and in pulmonary fibroblasts. Br J Pharmacol 2008, 155:606-616.
16. Merklinger S.L., Wagner R.A., Spiekerkoetter E., Hinek A., Knutsen R.H., Kabir M.G., et al. Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circ Res 2005, 97:596-604.
17. Morecroft I., Dempsie Y., Bader M., Walther D.J., Kotnik K., Loughlin L., et al. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension. Hypertension 2007, 49:232-236.
18. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. JBiol Chem 1992, 267:14998-15004.
19. Nitta C.H., Osmond D.A., Herbert L.M., Beasley B.F., Resta T.C., Walker B.R., et al. Role of ASIC1 in the development of chronic hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2014, 306:H41-H52. PubMed PMID: 24186095.
20. Piazza O., Leggiero E., De Benedictis G., Pastore L., Salvatore F., Tufano R., et al. S100B induces the release of pro-inflammatory cytokines in alveolar type I-like cells. Int J Immunopathol Pharmacol 2013, 26:383-391.
21. Queisser M.A., Kouri F.M., Königshoff M., Wygrecka M., Schubert U., Eickelberg O., et al. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 2008, 39:337-345.
22. Ramasamy R., Yan S.F., Schmidt A.M. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med 2005, 15:237-243.
23. Ranzato E., Patrone M., Pedrazzi M., Burlando B. Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via rage-dependent ERK1/2 activation. Cell Biochem Biophys 2010, 57:9-17.
24. Rose F., Grimminger F., Appel J., Heller M., Pies V., Weissmann N., et al. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells-role of hypoxia-inducible transcription factors. FASEB J 2002, 16:1660-1661.
25. Rubin L.J. Primary pulmonary hypertension. NEngl J Med 1997, 336:111-117.
26. Schmidt A.M., Yan S.D., Brett J., Mora R., Nowygrod R., Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. JClin Invest 1993, 91:2155-2168.
27. Schmidt A., Hori O., Brett J., Yan S., Wautier J., Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb Vasc Biol 1994, 14:1521-1528.
28. Spiekerkoetter E., Lawrie A., Merklinger S., Ambartsumian N., Lukanidin E., Schmidt A.-M., et al. Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways. Chest 2005, 128:577S.
29. Stenmark K.R., Fagan K.A., Frid M.G. Hypoxia-induced pulmonary vascular remodeling. Circ Res 2006, 99:675-691.
30. Stenmark K.R., Gerasimovskaya E., Nemenoff R.A., Das M. Hypoxic activation of adventitial fibroblasts. Chest 2002, 122:326S-334S.
31. Welsh D.J., Peacock A.J., MacLean M., Harnett M. Chronic hypoxia induces constitutive p38 mitogen-activated protein kinase activity that correlates with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries. Am J Respir Crit Care Med 2001, 164:282-289.
32. Welsh D.J., Scott P.H., Peacock A.J. p38 MAP kinase isoform activity and cell cycle regulators in the proliferative response of pulmonary and systemic artery fibroblasts to acute hypoxia. Pulm Pharmacol Ther 2006, 19:128-138.
33. Welsh D.J., Scott P., Plevin R., Wadsworth R., Peacock A.J. Hypoxia enhances cellular proliferation and inositol 1,4,5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery. Am J Respir Crit Care Med 1998, 158:1757-1762.
34. White K., Dempsie Y., Nilsen M., Wright A.F., Loughlin L., MacLean M.R. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. Cardiovasc Res 2011, 90:373-382.
35. Zong H., Madden A., Ward M., Mooney M.H., Elliott C.T., Stitt A.W. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. JBiol Chem 2010, 285:23137-23146.
36. Zuckerman B.D., Orton E.C., Stenmark K.R., Trapp J.A., Murphy J.R., Coffeen P.R., et al. Alteration of the pulsatile load in the high-altitude calf model of pulmonary hypertension. JAppl Physiol 1991, 70:859-868.